Literature DB >> 19578015

Study of gene-targeted mouse models of splicing factor gene Prpf31 implicated in human autosomal dominant retinitis pigmentosa (RP).

Kinga Bujakowska1, Cecilia Maubaret, Christina F Chakarova, Naoyuki Tanimoto, Susanne C Beck, Edda Fahl, Marian M Humphries, Paul F Kenna, Evgeny Makarov, Olga Makarova, François Paquet-Durand, Per A Ekström, Theo van Veen, Thierry Leveillard, Peter Humphries, Mathias W Seeliger, Shomi S Bhattacharya.   

Abstract

PURPOSE: Pre-mRNA processing factor 31 (PRPF31) is a ubiquitous protein needed for the assembly of the pre-mRNA splicing machinery. It has been shown that mutations in this gene cause autosomal dominant retinitis pigmentosa 11 (RP11), which is characterized by rod-cell degeneration. Interestingly, mutations in this ubiquitously expressed gene do not lead to phenotypes other than retinal malfunction. Furthermore, the dominant inheritance pattern has shown incomplete penetrance, which poses interesting questions about the disease mechanism of RP11.
METHODS: To characterize PRPF31 function in the rod cells, two animal models have been generated. One was a heterozygous knock-in mouse (Prpf31(A216P/+)) carrying a point mutation p.A216P, which has previously been identified in RP11 patients. The second was a heterozygous knockout mouse (Prpf31(+/-)). Retinal degeneration in RP11 mouse models was monitored by electroretinography and histology.
RESULTS: Generation of the mouse models is presented, as are results of ERGs and retinal morphology. No degenerative phenotype on fundus examination was found in Prpf31(A216P/+) and Prpf31(+/-) mice. Prpf31(A216P/A216P) and Prpf31(-/-) genotypes were embryonic lethal.
CONCLUSIONS: The results imply that Prpf31 is necessary for survival, and there is no compensation mechanism in mouse for the lack of this splicing factor. The authors suggest that p.A216P mutation in Prpf31 does not exert a dominant negative effect and that one Prpf31 wild-type allele is sufficient for maintenance of the healthy retina in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578015     DOI: 10.1167/iovs.08-3275

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 2.  RNA Splicing and Disease: Animal Models to Therapies.

Authors:  Matías Montes; Brianne L Sanford; Daniel F Comiskey; Dawn S Chandler
Journal:  Trends Genet       Date:  2018-11-19       Impact factor: 11.639

3.  The splicing factor Prp31 is essential for photoreceptor development in Drosophila.

Authors:  Payal Ray; Xiaoyan Luo; Elizabeth J Rao; Amina Basha; Elvin A Woodruff; Jane Y Wu
Journal:  Protein Cell       Date:  2010-04-17       Impact factor: 14.870

4.  Time Course of Disease Progression of PRPF31-mediated Retinitis Pigmentosa.

Authors:  Kelly Kiser; Kaylie D Webb-Jones; Sara J Bowne; Lori S Sullivan; Stephen P Daiger; David G Birch
Journal:  Am J Ophthalmol       Date:  2018-12-21       Impact factor: 5.258

5.  Three gene-targeted mouse models of RNA splicing factor RP show late-onset RPE and retinal degeneration.

Authors:  John J Graziotto; Michael H Farkas; Kinga Bujakowska; Bertrand M Deramaudt; Qi Zhang; Emeline F Nandrot; Chris F Inglehearn; Shomi S Bhattacharya; Eric A Pierce
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 6.  Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.

Authors:  Charles B Wright; Steven M Becker; Lucie A Low; Danilo A Tagle; Paul A Sieving
Journal:  J Ocul Pharmacol Ther       Date:  2019-06-05       Impact factor: 2.671

7.  PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa.

Authors:  Goranka Tanackovic; Adriana Ransijn; Philippe Thibault; Sherif Abou Elela; Roscoe Klinck; Eliot L Berson; Benoit Chabot; Carlo Rivolta
Journal:  Hum Mol Genet       Date:  2011-03-05       Impact factor: 6.150

8.  RNA Splicing Factor Mutations That Cause Retinitis Pigmentosa Result in Circadian Dysregulation.

Authors:  Iryna Shakhmantsir; Scott J Dooley; Siddharth Kishore; Dechun Chen; Eric Pierce; Jean Bennett; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2019-11-15       Impact factor: 3.182

Review 9.  Prevalence and novelty of PRPF31 mutations in French autosomal dominant rod-cone dystrophy patients and a review of published reports.

Authors:  Isabelle Audo; Kinga Bujakowska; Saddek Mohand-Saïd; Marie-Elise Lancelot; Veselina Moskova-Doumanova; Naushin H Waseem; Aline Antonio; José-Alain Sahel; Shomi S Bhattacharya; Christina Zeitz
Journal:  BMC Med Genet       Date:  2010-10-12       Impact factor: 2.103

10.  Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies.

Authors:  Mingchu Xu; Yajing Angela Xie; Hana Abouzeid; Christopher T Gordon; Alessia Fiorentino; Zixi Sun; Anna Lehman; Ihab S Osman; Rachayata Dharmat; Rosa Riveiro-Alvarez; Linda Bapst-Wicht; Darwin Babino; Gavin Arno; Virginia Busetto; Li Zhao; Hui Li; Miguel A Lopez-Martinez; Liliana F Azevedo; Laurence Hubert; Nikolas Pontikos; Aiden Eblimit; Isabel Lorda-Sanchez; Valeria Kheir; Vincent Plagnol; Myriam Oufadem; Zachry T Soens; Lizhu Yang; Christine Bole-Feysot; Rolph Pfundt; Nathalie Allaman-Pillet; Patrick Nitschké; Michael E Cheetham; Stanislas Lyonnet; Smriti A Agrawal; Huajin Li; Gaëtan Pinton; Michel Michaelides; Claude Besmond; Yumei Li; Zhisheng Yuan; Johannes von Lintig; Andrew R Webster; Hervé Le Hir; Peter Stoilov; Jeanne Amiel; Alison J Hardcastle; Carmen Ayuso; Ruifang Sui; Rui Chen; Rando Allikmets; Daniel F Schorderet
Journal:  Am J Hum Genet       Date:  2017-03-09       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.